OLINVACIMAB

UNII: VFH55IZ5VI
Preferred Substance Name: OLINVACIMAB

2095504-49-5
FULLY HUMAN MONOCLONAL ANTIBODY TARGETS VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2) (HUMAN MONOCLONAL TTAC-0001 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL TTAC-0001 LIGHT CHAIN, DIMER
OLINVACIMAB [INN]
TANIBIRUMAB
TTAC-0001

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

OLINVACIMAB

Synonyms and Mappings

Resources

Note